CompuGroup Medical (UK) Performance
| 0MSD Stock | 16.22 6.76 29.42% |
CompuGroup Medical holds a performance score of 7 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.42, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CompuGroup Medical will likely underperform. Use CompuGroup Medical semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and information ratio , to analyze future returns on CompuGroup Medical.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in CompuGroup Medical AG are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, CompuGroup Medical unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0363 | Payout Ratio 1.2686 |
1 | Germany stocks higher at close of trade DAX up 1.00 percent - Investing.com | 12/04/2024 |
2 | CompuGroup stock soars 31 percent on CVC deal - Investing.com | 12/09/2024 |
| Begin Period Cash Flow | 90.5 M | |
| Free Cash Flow | 104.1 M |
CompuGroup |
CompuGroup Medical Relative Risk vs. Return Landscape
If you would invest 1,595 in CompuGroup Medical AG on November 29, 2024 and sell it today you would earn a total of 27.00 from holding CompuGroup Medical AG or generate 1.69% return on investment over 90 days. CompuGroup Medical AG is generating 1.7104% of daily returns and assumes 18.9147% volatility on return distribution over the 90 days horizon. Simply put, majority of traded equity instruments are less risky than CompuGroup on the basis of their historical return distribution, and most equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
CompuGroup Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CompuGroup Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CompuGroup Medical AG, and traders can use it to determine the average amount a CompuGroup Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0904
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | 0MSD | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 18.91 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.71 actual daily | 34 66% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average CompuGroup Medical is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CompuGroup Medical by adding it to a well-diversified portfolio.
CompuGroup Medical Fundamentals Growth
CompuGroup Stock prices reflect investors' perceptions of the future prospects and financial health of CompuGroup Medical, and CompuGroup Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CompuGroup Stock performance.
| Return On Equity | 0.0379 | ||||
| Return On Asset | 0.0305 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 1.96 B | ||||
| Shares Outstanding | 49.56 M | ||||
| Price To Sales | 1.69 X | ||||
| Revenue | 1.19 B | ||||
| Gross Profit | 380.68 M | ||||
| EBITDA | 215.84 M | ||||
| Net Income | 46.87 M | ||||
| Total Debt | 766.94 M | ||||
| Book Value Per Share | 12.26 X | ||||
| Cash Flow From Operations | 179.53 M | ||||
| Earnings Per Share | 1.44 X | ||||
| Total Asset | 1.9 B | ||||
About CompuGroup Medical Performance
Assessing CompuGroup Medical's fundamental ratios provides investors with valuable insights into CompuGroup Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the CompuGroup Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
CompuGroup Medical is entity of United Kingdom. It is traded as Stock on LSE exchange.Things to note about CompuGroup Medical performance evaluation
Checking the ongoing alerts about CompuGroup Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CompuGroup Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CompuGroup Medical is way too risky over 90 days horizon | |
| CompuGroup Medical appears to be risky and price may revert if volatility continues | |
| CompuGroup Medical is unlikely to experience financial distress in the next 2 years | |
| About 56.0% of the company shares are owned by insiders or employees |
- Analyzing CompuGroup Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CompuGroup Medical's stock is overvalued or undervalued compared to its peers.
- Examining CompuGroup Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CompuGroup Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CompuGroup Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CompuGroup Medical's stock. These opinions can provide insight into CompuGroup Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for CompuGroup Stock Analysis
When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.